Protein formulation, preparation method therefor and use thereof

AU2022438138B2Pending Publication Date: 2026-07-23BEIJING LIANGYUAN BIO-SCI LLC
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
BEIJING LIANGYUAN BIO-SCI LLC
Filing Date
2022-10-27
Publication Date
2026-07-23

Smart Images

  • Figure 00000001_0000
    Figure 00000001_0000
  • Figure 00000001_0001
    Figure 00000001_0001
  • Figure 00000037_0000
    Figure 00000037_0000
Patent Text Reader

Abstract

The present invention relates to a protein formulation, a preparation method therefor and a use thereof. The formulation is an aqueous solvent, and comprises: (1) a cytokine protein having a concentration of greater than 1 mg / ml; (2) poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE); and (3) an essential pH regulator / buffer. The cytokine includes but is not limited to: IL2, IL4, IL7, IL9, IL10, IL15, IL21, G-CSF, GM-CSF, IFN, EPO, GF, and TNF. The formulation is used for preparing drugs or formulations administered by means of subcutaneous injection.
Need to check novelty before this filing date? Find Prior Art